QI
QTTB icon

QS Investors’s Q32 Bio QTTB Stock Holding History

QS Investors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$185K Buy
+1,411
New +$176K ﹤0.01% 1073

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

QS Investors's QTTB Position: Q2 2021 in Review

QS Investors opened a new position in Q32 Bio (QTTB) in Q2 2021: 1,411 shares worth $185K. The stake represents ﹤0.01% of the portfolio and ranks #1073 among its holdings.

118 funds tracked by Wall St. Rank hold QTTB as of Q2 2021.

  • QS Investors held 1,411 shares of Q32 Bio worth $185K as of Q2 2021.
  • Q32 Bio was a new QS Investors position in Q2 2021.
  • Q32 Bio made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #1073 holding.
  • 118 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.